30th Apr 2024 7:00 am |
RNS |
Cancellation - Byotrol Plc |
29th Apr 2024 2:15 pm |
RNS |
Secondary Trading on Asset Match |
23rd Apr 2024 6:00 pm |
RNS |
Byotrol |
22nd Apr 2024 4:44 pm |
RNS |
Capital Reorganisation Delay |
22nd Apr 2024 1:27 pm |
RNS |
Results of General Meeting |
15th Apr 2024 11:48 am |
RNS |
Holding(s) in Company |
8th Apr 2024 7:00 am |
RNS |
Holding(s) in Company |
2nd Apr 2024 3:27 pm |
RNS |
Director Dealing |
28th Mar 2024 7:00 am |
RNS |
Proposed Cancellation |
22nd Dec 2023 11:44 am |
RNS |
Holding(s) in Company |
7th Dec 2023 7:00 am |
RNS |
Half-year Report |
14th Nov 2023 7:00 am |
RNS |
Launch of PROCESSUS® Instrument Decontamination |
14th Nov 2023 7:00 am |
RNS |
Trading Update |
9th Nov 2023 3:43 pm |
RNS |
Holding(s) in Company |
27th Sep 2023 7:00 am |
RNS |
Board Changes |
13th Sep 2023 3:33 pm |
RNS |
Result of AGM |
8th Sep 2023 4:33 pm |
RNS |
Director Dealing |
7th Sep 2023 7:01 am |
RNS |
Board Appointment |
7th Sep 2023 7:00 am |
RNS |
Trading Update |
29th Aug 2023 8:51 am |
RNS |
Launch of CHEMGENE MEDLAB into human healthcare |
23rd Aug 2023 7:00 am |
RNS |
Investor Presentation via Investor Meet Company |
31st Jul 2023 7:00 am |
RNS |
Final Results |
6th Jul 2023 7:00 am |
RNS |
Patent Grant for Novel Anti-viral Seaweed Extract |
24th May 2023 3:14 pm |
RNS |
US EPA approves Byotrol24 as long-lasting virucide |
24th May 2023 8:51 am |
RNS |
Director Dealing |
28th Apr 2023 9:57 am |
RNS |
Director Dealing |
27th Apr 2023 7:00 am |
RNS |
Trading Update and Board Changes |
1st Feb 2023 9:52 am |
RNS |
Director Dealing |
22nd Dec 2022 3:08 pm |
RNS |
Director Dealing |
19th Dec 2022 10:00 am |
RNS |
Director Dealing |
16th Dec 2022 7:00 am |
RNS |
Grant of Share Incentive Awards |
12th Dec 2022 7:00 am |
RNS |
Interim results and Investor Presentation |
22nd Nov 2022 7:00 am |
RNS |
Directorate Changes |
27th Sep 2022 11:15 am |
RNS |
PDMR Shareholding |
22nd Sep 2022 5:21 pm |
RNS |
Result of AGM |
8th Sep 2022 7:00 am |
RNS |
Director Dealing |
2nd Sep 2022 10:02 am |
RNS |
Investor Presentation |
30th Aug 2022 7:00 am |
RNS |
Final Results |
12th Aug 2022 3:30 pm |
RNS |
Director Dealing |
28th Jul 2022 7:00 am |
RNS |
Completion of Convertible Loan Note Fundraising |